| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |